Complications of intravenous immune globulin treatment in neurologic disease.
Achiron
A
A
D000293:Adolescent; D000328:Adult; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects* / Q000627:therapeutic use; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000628:therapy*; D012737:Sex Factors; D016896:Treatment Outcome
D016756:Immunoglobulins, Intravenous